Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date20 Jun 2019 |
100 Clinical Results associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
0 Patents (Medical) associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
100 Deals associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
100 Translational Medicine associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.